These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 29513203)

  • 21. Negative ionotropic agents for the treatment of left ventricular outflow tract obstruction due to sigmoid septum and concentric left ventricular hypertrophy.
    Ranasinghe I; Yeoh T; Yiannikas J
    Heart Lung Circ; 2011 Sep; 20(9):579-86. PubMed ID: 21684204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy.
    Sherrid MV; Barac I; McKenna WJ; Elliott PM; Dickie S; Chojnowska L; Casey S; Maron BJ
    J Am Coll Cardiol; 2005 Apr; 45(8):1251-8. PubMed ID: 15837258
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Left ventricular outflow tract pressure gradient changes after carvedilol-disopyramide cotherapy in a cat with hypertrophic obstructive cardiomyopathy.
    Hori Y; Fujimoto E; Nishikawa Y; Nakamura T
    J Vet Cardiol; 2020 Jun; 29():40-46. PubMed ID: 32464577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An equation to predict the changes in peak left ventricular pressure in hypertrophic obstructive cardiomyopathy after treatment: application to the administration of disopyramide.
    Niki K; Sugawara M; Tanino S; Iwade K; Hosoda S; Kasanuki H
    Heart Vessels; 1999; 14(2):72-81. PubMed ID: 10651183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paradoxical response to exercise in asymptomatic hypertrophic cardiomyopathy: a new description of outflow tract obstruction dynamics.
    Lafitte S; Reant P; Touche C; Pillois X; Dijos M; Arsac F; Peyrou J; Montaudon M; Ritter P; Roudaut R; Demaria A
    J Am Coll Cardiol; 2013 Aug; 62(9):842-50. PubMed ID: 23810875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characteristics and surgical outcomes of symptomatic patients with hypertrophic cardiomyopathy with abnormal papillary muscle morphology undergoing papillary muscle reorientation.
    Kwon DH; Smedira NG; Thamilarasan M; Lytle BW; Lever H; Desai MY
    J Thorac Cardiovasc Surg; 2010 Aug; 140(2):317-24. PubMed ID: 20038476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Marked right ventricular outflow obstruction in two children with hypertrophic cardiomyopathy].
    Matsunaga S; Rikitake N; Yoshioka F; Kato H
    J Cardiogr; 1985 Sep; 15(3):931-9. PubMed ID: 3837078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mid-term outcomes of biventricular obstruction and left ventricular outflow tract obstruction after surgery correction in child and adolescent patients with hypertrophic cardiomyopathy.
    Zhai S; Xu H; Fan C; Yang Y; Hang F; Guo X; Wang H; Duan F; Yan J
    PLoS One; 2018; 13(2):e0192218. PubMed ID: 29408870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Danger of use of disopyramide in patients with hypertrophic obstructive cardiomyopathy. An electrophysiologic study.
    Miyajima S; Aizawa Y; Matsuoka A; Okabe M; Shibata A
    Jpn Heart J; 1988 Jan; 29(1):115-9. PubMed ID: 3398239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disopyramide in hypertrophic cardiomyopathy. I. Hemodynamic assessment after intravenous administration.
    Pollick C; Kimball B; Henderson M; Wigle ED
    Am J Cardiol; 1988 Dec; 62(17):1248-51. PubMed ID: 3195486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A standard echocardiographic and tissue Doppler study of morphological and functional findings in children with hypertrophic cardiomyopathy compared to those with left ventricular hypertrophy in the setting of Noonan and LEOPARD syndromes.
    Cerrato F; Pacileo G; Limongelli G; Gagliardi MG; Santoro G; Digilio MC; Di Salvo G; Ardorisio R; Miele T; Calabrò R
    Cardiol Young; 2008 Dec; 18(6):575-80. PubMed ID: 18842161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypertrophic cardiomyopathy: is a left ventricular outflow tract gradient a major prognostic determinant?
    Romeo F; Pelliccia F; Cristofani R; Martuscelli E; Reale A
    Eur Heart J; 1990 Mar; 11(3):233-40. PubMed ID: 2318227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of intravenous disopyramide on coronary hemodynamics and vasodilator reserve in hypertrophic obstructive cardiomyopathy.
    Hongo M; Nakatsuka T; Takenaka H; Tanaka M; Watanabe N; Yazaki Y; Sekiguchi M
    Cardiology; 1996; 87(1):6-11. PubMed ID: 8631046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypertrophic cardiomyopathy with right ventricular outflow tract and left ventricular intracavitary obstruction.
    Malik R; Maron MS; Rastegar H; Pandian NG
    Echocardiography; 2014 May; 31(5):682-5. PubMed ID: 24649889
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relation between left ventricular outflow tract obstruction and left ventricular shape in patients with hypertrophic cardiomyopathy: a cardiac magnetic resonance imaging study.
    Martin R; Lairez O; Boudou N; Méjean S; Lhermusier T; Dumonteil N; Berry M; Cognet T; Massabuau P; Elbaz M; Rousseau H; Galinier M; Carrié D
    Arch Cardiovasc Dis; 2013; 106(8-9):440-7. PubMed ID: 23906680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of septal myectomy on left atrial volume and left ventricular diastolic filling patterns: an echocardiographic study of young patients with obstructive hypertrophic cardiomyopathy.
    Menon SC; Ackerman MJ; Ommen SR; Cabalka AK; Hagler DJ; O'Leary PW; Dearani JA; Cetta F; Eidem BW
    J Am Soc Echocardiogr; 2008 Jun; 21(6):684-8. PubMed ID: 18187287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tissue Doppler imaging during exercise stress echocardiography demonstrates a mechanism for impaired exercise performance in children with hypertrophic cardiomyopathy.
    Ferguson ME; Sachdeva R; Gillespie SE; Morrow G; Border W
    Echocardiography; 2016 Nov; 33(11):1718-1725. PubMed ID: 27545012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypertrophic cardiomyopathy in infants: clinical features and natural history.
    Maron BJ; Tajik AJ; Ruttenberg HD; Graham TP; Atwood GF; Victorica BE; Lie JT; Roberts WC
    Circulation; 1982 Jan; 65(1):7-17. PubMed ID: 6458422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effective disopyramide treatment in a boy with mid-ventricular hypertrophic obstructive cardiomyopathy.
    Teraguchi M; Ikemoto Y; Kobayashi Y
    Circ J; 2002 Jul; 66(7):709-11. PubMed ID: 12135145
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sequential Atrioventricular Pacing in Patients With Hypertrophic Cardiomyopathy: An 18-year Experience.
    Jurado Román A; Montero Cabezas JM; Rubio Alonso B; García Tejada J; Hernández Hernández F; Albarrán González-Trevilla A; Velázquez Martín MT; Coma Samartín R; Rodríguez García J; Tascón Pérez JC
    Rev Esp Cardiol (Engl Ed); 2016 Apr; 69(4):377-83. PubMed ID: 26719031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.